Antibiogramme des Chlamydia et des mycoplasmes

Barbeyrac (de), 1993, Chlamydia trachomatis et tétracyclines: influence de l'inoculum, Abstract no 169/P10, 173 Bebear, 1985, Activité comparée de la minocycline et doxycycline sur les mycoplasmes pathogènes pour l'homme, Pathol. Biol., 33, 577 Bebear, 1990, Pristinamycin and human mycoplasmas: in vitro activity compared with macrolides and lincosamides, in vivo efficacy in Mycoplasma pneumoniae experimental infection, Zbl. Bakt., 77 Bebear, 1991, Les infections à mycoplasmes génitaux, Rev. Eur. Dermatol. MST, 3, 307 Bebear, 1993, Potential improvements in therapeutic options for mycoplasmal respiratory infections, Clin. Infect. Dis., 17, S 202, 10.1093/clinids/17.Supplement_1.S202 Bianchi, 1991, Étude comparative des concentrations minimales inhibitrices (CMI) et des concentrations minimales léthales (CML) de la tétracycline, de la minocycline, de l'érythromycine et de la rokitamycine sur onze souches de Chlamydia trachomatis, Pathol. Biol., 39, 442 Brunet, 1989, Detection of tetracycline-resistant strains of Ureaplasma urealyticum by hybridization assays, Eur. J. Clin. Microbiol. Infect. Dis., 8, 636, 10.1007/BF01968147 Cantet, 1983, Activité comparée in vitro de sept quinolones sur Ureaplasma urealyticum, Pathol. Biol., 31, 501 Cassell, 1991, Efficacy of clarithromycin against Mycoplasma pneumoniae, J. Antimicrob. Chemother., 27, 47, 10.1093/jac/27.suppl_A.47 Cassell, 1993, Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns, Clin. Microbiol. Rev., 6, 69, 10.1128/CMR.6.1.69 Dailloux, 1990, Sensibilité in vitro des Chlamydiae aux antibiotiques, Pathol. Biol., 38, 426 Dailloux, 1994, Observation en microscopie électronique de l'action de l'érythromycine, doxycycline, et ofloxacine sur le cycle de multiplication de Chlamydia trachomatis, Pathol. Biol., 42, 399 Ehret, 1988, Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies, Antimicrob. Agents Chemother., 32, 1295, 10.1128/AAC.32.9.1295 Flemingham, 1991, The in vitro activity of some 14-, 15-, and 16-membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum, Drugs Exptl. Clin. Res., 17, 91 Hammerschlag, 1994, Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae, Antimicrob. Agents Chemother., 38, 1873, 10.1128/AAC.38.9.1873 Jones, 1990, Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics, J. Infect. Dis., 162, 1309, 10.1093/infdis/162.6.1309 Kenny, 1989, Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method, Antimicrob. Agents Chemother., 33, 103, 10.1128/AAC.33.1.103 Kenny, 1991, Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline and erythromycin, Antimicrob. Agents Chemother., 35, 587, 10.1128/AAC.35.3.587 Kenny, 1991, Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and Win 57273, Antimicrob. Agents Chemother., 35, 1515, 10.1128/AAC.35.7.1515 Nakata, 1992, In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis, Antimicrob. Agents Chemother., 36, 188, 10.1128/AAC.36.1.188 Niitu, 1970, Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics, J. Pediatr., 76, 438, 10.1016/S0022-3476(70)80485-1 Niitu, 1974, In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae, Antimicrob. Agents Chemother., 5, 513, 10.1128/AAC.5.5.513 Peeling, 1994, Standardization of antimicrobial susceptibility testing for Chlamydia trachomatis, 346 Renaudin, 1991, In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones and a streptogramin, Eur. J. Clin. Microbiol. Infect. Dis., 10, 984, 10.1007/BF02005461 Renaudin, 1992, In vitro susceptibility of Mycoplasma genitalium to antibiotics, Antimicrob. Agents Chemother., 36, 870, 10.1128/AAC.36.4.870 Renaudin, 1992, Activité in vitro de la sparfloxacine sur les mycoplasmes, Pathol. Biol., 40, 450 Roberts, 1985, Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences, Antimicrob. Agents Chemother., 28, 141, 10.1128/AAC.28.1.141 Roberts, 1986, Dissemination of the tetM tetracycline resistant determinant to Ureaplasma urealyticum, Antimicrob. Agents Chemother., 29, 350, 10.1128/AAC.29.2.350 Roberts, 1992, Antibiotic resistance in mycoplasmas, 513 Robertson, 1981, Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosamicin, Antimicrob. Agents Chemother., 20, 53, 10.1128/AAC.20.1.53 Rylander, 1988, In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new quinolone CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum, Scand. J. Infect. Dis., 12 Scieux, 1990, In vitro activity of azithromycin against Chlamydia trachomatis, J. Antimicrob. Chemother., 25, S7, 10.1093/jac/25.suppl_A.7 Shepard, 1976, Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material, J. Clin. Microbiol., 3, 613, 10.1128/jcm.3.6.613-625.1976 Stopler, 1980, Antibiotic-resistant mutants of Mycoplasma pneumoniae, Isr. J. Med. Sci., 16, 169 Waites, 1991, In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to sparfloxacin and P.D. 127391, Antimicrob. Agents. Chemother., 35, 1181, 10.1128/AAC.35.6.1181 Waites, 1991, Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum, Diagn. Microbiol. Infect. Dis., 14, 1, 10.1016/0732-8893(91)90041-D Welsh, 1992, In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae, Antimicrob. Agents Chemother., 36, 291, 10.1128/AAC.36.2.291